Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,555,140
+$1,120,527 QoQ
Shares Held
1,455,514
+3.1% QoQ
Ownership
0.570%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $776,969,626 across 46 Drug Manufacturers - Specialty & Generic names. BCRX ranks #9 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,567,388 | $256,352,500 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,916,666 | $132,696,643 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
207,093 | $112,209,199 | |
| 4 | VTRS |
Viatris Inc
|
4,069,647 | $64,625,993 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
314,451 | $52,997,570 | |
| 6 | ALKS |
Alkermes plc.
|
393,524 | $20,620,657 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
711,233 | $17,503,443 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,012,792 | $15,941,311 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,555,140 | 1,455,514 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $13,434,613 | 1,411,199 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,645,791 | 210,999 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,716,590 | 226,165 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $10,792,166 | 1,204,483 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $7,359,134 | 981,218 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,068,623 | 275,083 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,898,060 | 249,745 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $1,645,566 | 266,273 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $1,405,589 | 276,691 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $1,851,227 | 309,053 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $2,731,336 | 385,782 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,566,536 | 364,565 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,446,030 | 173,385 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,892,683 | 164,868 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,059,507 | 163,453 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,977,792 | 186,937 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $2,982,847 | 183,447 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,182,233 | 157,562 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,263,949 | 157,547 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $728,255 | 46,063 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $504,146 | 49,572 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $384,293 | 51,583 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $126,828 | 36,869 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $194,783 | 40,921 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $82,654 | 41,327 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||